Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05489380 · ClinicalTrials.gov registry record · NA
Optical Diagnosis Versus Laser Measurement of Polyps' Size During Colonoscopy and Implications for Surveillance
A NA study of Colorectal Polyp, sponsored by Radboud University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 138
- Enrollment target
- 3
- Study locations
NCT05489380: Completed NA study of Colorectal Polyp, sponsored by Radboud University Medical Center.
NCT05489380 is a NA study of Colorectal Polyp that has completed, run by Radboud University Medical Center. The registered enrollment target is 138 participants, below the 2,757-participant average among 4 other Colorectal Polyp trials with a reported enrollment target (95% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05489380, a NA study of Colorectal Polyp, has completed, sponsored by Radboud University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 138 participants
- Enrollment target
- 3
- Study locations
Study Summary
Recent updates of the guidelines on polyp surveillance of the American Society of Gastrointestinal Endoscopy (ASGE) and European Society of Gastrointestinal Endoscopy (ESGE) increasingly focus on size of polyps as an important indicator of malignant transformation to colorectal cancer (CRC). However, the interobserver variability in polyp size assessment between optical diagnosis of endoscopists and pathologists is considerable. This may lead to incorrect surveillance intervals in patients at risk for developing colorectal cancer, which may increase the risk of post-colonoscopy CRC (PCCRC). This study aims to assess the precision of a new laser-based measurement system (AccuMeasure, VTM Technologies Ltd.) for polyps during colonoscopy.
Primary Outcome
interobserver agreement between AccuMeasure and biopsy forceps assisted measurement
Conditions Studied
Interventions
- DEVICE AccuMeasure
Study Locations (3)
Indiana
- Indiana University Hospital - Indianapolis
New York
- NYU Langone Health - New York
Gelderland
- Radboud university medical center - Nijmegen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 138 participants |
| Start Date | 2023-06-19 |
| Est. Completion | 2026-03-01 |
| Phase | NA |
What the finished NCT05489380 record still lists
NCT05489380 is an interventional study that assigns participants to a tested intervention. The registered 138 participants enrollment target is mid-sized for trials with a published cap, below the 2,757-participant average among 4 other Colorectal Polyp trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Colorectal Polyp appearing as the primary indexed condition, and to 1 intervention - of which AccuMeasure is the first listed.
NCT05489380 reports a single indexed study location in Indiana, New York, Gelderland.
Frequently Asked Questions
What is clinical trial NCT05489380 about?
NCT05489380 is a clinical study titled "Optical Diagnosis Versus Laser Measurement of Polyps' Size During Colonoscopy and Implications for Surveillance". Recent updates of the guidelines on polyp surveillance of the American Society of Gastrointestinal Endoscopy (ASGE) and European Society of Gastrointestinal Endoscopy (ESGE) increasingly focus on size of polyps as an important indicator of malignant transformation to colorectal cancer (CRC). However...
What is the current status of trial NCT05489380?
This trial is currently completed. It is a NA study. The enrollment target is 138 participants. The study started on 2023-06-19. Estimated completion is 2026-03-01.
What conditions does trial NCT05489380 study?
This clinical trial studies the following conditions: Colorectal Polyp.
What interventions are being tested in trial NCT05489380?
The interventions under investigation include: AccuMeasure (DEVICE).
Who is sponsoring clinical trial NCT05489380?
This trial is sponsored by Radboud University Medical Center, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05489380 being conducted?
This trial has 3 study locations across Indiana, New York, Gelderland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Polyp
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Feasibility and Colorectal Benefits of Pulses Supplementation
RECRUITING · NA
-
PARADIGM - En Bloc Trial With the EndoQuest Endoluminal Surgical (ELS) System
RECRUITING · NA
-
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
RECRUITING · NA
-
Early Detection of Advanced Adenomas and Colorectal Cancer
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04402788 · 138 participants · Phase 2
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
- NCT04883255 · 138 participants · Early Phase 1
Cannabis Use, Cognition, and the Endocannabinoid System in HIV
- NCT05620784 · 138 participants · Phase 3
Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEP
- NCT05832086 · 138 participants · Phase 2
Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI